Diffusion-perfusion MRI for triaging transient ischemic attack and acute cerebrovascular syndromes

Current Opinion in Neurology

Volumn 24, Issue 1, 2011, Pages 44-49

  Olivot, Jean Marc ^a   Albers, Gregory W ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

brain infarction; MRI diffusion and perfusion; transient ischemic attack; triage

Indexed keywords

ALTEPLASE; DESMOTEPLASE; PLACEBO;

BLOOD CLOT LYSIS; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; COMPUTER PROGRAM; DIFFUSION WEIGHTED IMAGING; EMERGENCY HEALTH SERVICE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; REVIEW; TISSUE INJURY; TRANSIENT ISCHEMIC ATTACK;

ACUTE DISEASE; AGED; BRAIN ISCHEMIA; CEREBROVASCULAR DISORDERS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PERFUSION; THROMBOLYTIC THERAPY; TRIAGE;

EID: 78651403207     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e328341f8a5     Document Type: Review

References (48)

1. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia: the ischemic penumbra. Stroke 1981; 12:723-725.
2. Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994; 36:557-565.
3. Furlan M, Marchal G, Viader F, et al. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol 1996; 40:216-226.
4. Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375:1695-1703.
5. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 h after acute ischemic stroke. N Engl J Med 2008; 359:1317-1329.
6. Castle J, Mlynash M, Lee K, et al. Agreement regarding diagnosis of transient ischemic attack fairly low among stroke-trained neurologists. Stroke 2010; 41:1367-1370.
7. Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 2007; 6:1063-1072.
8. Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007; 369:283-292.
9. Purroy F, Montaner J, Molina CA, et al. Patterns and predictors of early risk of recurrence after transient ischemic attack with respect to etiologic subtypes. Stroke 2007; 38:3225-3229.
10. Calvet D, Touze E, Oppenheim C, et al. DWI lesions and TIA etiology improve the prediction of stroke after TIA. Stroke 2009; 40:187-192.
11. Coutts SB, Simon JE, Eliasziw M, et al. Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging. Ann Neurol 2005; 57:848-854.
12. Ay H, Arsava EM, Johnston SC, et al. Clinical-and imaging-based prediction of stroke risk after transient ischemic attack: the CIP model. Stroke 2009; 40:181-186.
13. Kidwell CS, Chalela JA, Saver JL, et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 2004; 292:1823-1830.
14. Donnan GA, Baron JC, Ma H, Davis SM. Penumbral selection of patients for trials of acute stroke therapy. Lancet Neurol 2009; 8:261-269.
15. Moseley ME, Cohen Y, Kucharczyk J, et al. Diffusion-weighted MR imaging of anisotropic water diffusion in cat central nervous system. Radiology 1990; 176:439-445.
16. Hossmann KA, Fischer M, Bockhorst K, et al. NMR imaging of the apparent diffusion coefficient (ADC) for the evaluation of metabolic suppression and recovery after prolonged cerebral ischemia. J Cereb Blood Flow Metab 1994; 14:723-731.
17. Davis DP, Robertson T, Imbesi SG. Diffusion-weighted magnetic resonance imaging versus computed tomography in the diagnosis of acute ischemic stroke. J Emerg Med 2006; 31:269-277.
18. Oppenheim C, Samson Y, Manai R, et al. Prediction of malignant middle cerebral artery infarction by diffusion-weighted imaging. Stroke 2000; 31:2175-2181.
19. Vahedi K, Hofmeijer J, Juettler E, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: A pooled analysis of three randomised controlled trials. Lancet Neurol 2007; 6:215-222. (Pubitemid 46237760)
20. Selim M, Fink JN, Kumar S, et al. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume. Stroke 2002; 33:2047-2052.
21. Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the Diffusion and Perfusion Imaging Evaluation For Understanding Stroke Evolution (DEFUSE) study. Ann Neurol 2006; 60:508-517.
22. Davis SM, Donnan GA, Parsons MW, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008; 7:299-309.
23. Mlynash M, De Silva DA, Lansberg MG, et al. Optimal definition of malignant profile in the DEFUSE-EPITHET pooled database. Stroke 2010; 41:e207.
24. Yoo AJ, Verduzco LA, Schaefer PW, et al. MRI-based selection for intraarterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization. Stroke 2009; 40:2046-2054.
25. Redgrave JN, Coutts SB, Schulz UG, et al. Systematic review of associations between the presence of acute ischemic lesions on diffusion-weighted imaging and clinical predictors of early stroke risk after transient ischemic attack. Stroke 2007; 38:1482-1488.
26. Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke 2009; 40:2276-2293.
27. Giles MF, Albers GW, Amarenco P, et al. Addition of brain infarction to the ABCD2 Score (ABCD2I). A collaborative analysis of unpublished data on .4574. patients. Stroke 2010; 41:1907-1913.
28. Kane I, Sandercock P, Wardlaw J. Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date. J Neurol Neurosurg Psychiatry 2007; 78:485-491.
29. Christensen S, Mouridsen K, Wu O, et al. Comparison of 10 perfusion MRI parameters in 97 sub-6-h stroke patients using voxel-based receiver operating characteristics analysis. Stroke 2009; 40:2055-2061.
30. Calamante F, Christensen S, Desmond PM, et al. The physiological signifi-cance of the time-to-maximum (Tmax) parameter in perfusion MRI. Stroke 2010; 41:1169-1174.
31. Olivot JM, Mlynash M, Thijs VN, et al. Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Stroke 2009; 40:469-475.
32. Takasawa M, Jones PS, Guadagno JV, et al. How reliable is perfusion MR in acute stroke? Validation and determination of the penumbra threshold against quantitative PET. Stroke 2008; 39:870-877.
33. Olivot JM, Mlynash M, Zaharchuk G, et al. Perfusion MRI (Tmax and MTT) correlation with xenon CT cerebral blood flow in stroke patients. Neurology 2009; 72:1140-1145.
34. Kim JH, Bang OY, Liebeskind DS, et al. Impact of baseline tissue status (diffusion-weighted imaging lesion) versus perfusion status (severity of hypoperfusion) on hemorrhagic transformation. Stroke 2010; 41:e135-e142.
35. Campbell BC, Christensen S, Butcher KS, et al. Regional very low cerebral blood volume predicts hemorrhagic transformation better than diffusionweighted imaging volume and thresholded apparent diffusion coefficient in acute ischemic stroke. Stroke 2010; 41:82-88.
36. Mlynash M, Olivot JM, Tong DC, Lansberg MG, et al. Yield of combined perfusion and diffusion MR imaging in hemispheric TIA. Neurology 2009; 72:1127-1133.
37. Krol AL, Coutts SB, Simon JE, Hill MD, et al. Perfusion MRI abnormalities in speech or motor transient ischemic attack patients. Stroke 2005; 36:2487-2489.
38. Perez A, Restrepo L, Kleinman JT, et al. Patients with diffusion-perfusion mismatch on magnetic resonance imaging 48 h or more after stroke symptom onset: clinical and imaging features. J Neuroimaging 2006; 16:329-333.
39. Ibaraki M, Ito H, Shimosegawa E, et al. Cerebral vascular mean transit time in healthy humans: a comparative study with PET and dynamic susceptibility contrast enhanced MRI. J Cereb Blood Flow Metab 2007; 27:404-413.
40. Ma H, Zavala JA, Teoh H, et al. Penumbral mismatch is underestimated using standard volumetric methods and this is exacerbated with time. J Neurol Neurosurg Psychiatry 2009; 80:991-996.
41. Olivot JM, Mlynash M, Thijs VN, et al. Geography, structure, and evolution of diffusion and perfusion lesions in Diffusion and perfusion imaging Evaluation For Understanding Stroke Evolution (DEFUSE). Stroke 2009; 40:3245-3251.
42. Olivot JM, Mlynash M, Thijs VN, et al. Relationships between cerebral perfusion and reversibility of acute diffusion lesions in DEFUSE: insights from RADAR. Stroke 2009; 40:1692-1697.
43. Chemmanam T, Campbell BC, Christensen S, et al. Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion: diffusion mismatch. Neurology 2010; 21:1040-1047.
44. Rosso C, Hevia-Montiel N, Deltour S, et al. Prediction of infarct growth based on apparent diffusion coefficients: penumbral assessment without intravenous contrast material. Radiology 2009; 250:184-192.
45. Hacke W, Furlan AJ, Al-Rawi Y, et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009; 8:141-150.
46. Campbell BC, Christensen S, Foster SJ, et al. Visual assessment of perfusion-diffusion mismatch is inadequate to select patients for thrombolysis. Cerebrovasc Dis 2010; 29:592-596.
47. Davis SM, Donnan GA. MR mismatch and thrombolysis: appealing but validation required. Stroke 2009; 40:2910.
48. Fiebach JB, Schellinger PD. MR mismatch is useful for patient selection for thrombolysis: yes. Stroke 2009; 40:2906-2907.